AFP1h
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
FDA approves painkiller designed to eliminate the risks of addiction associated with opioids
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
Hosted on MSN56m
The most steel I've ever cut through
"Scientists create the world’s first living robot, opening new doors in biotechnology. ColdFusion offers captivating, ...
Opinion
Williamsport Sun-Gazette23mOpinion
What other newspapers are saying: Pharmacy benefit practices must be reformed
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...